European regulators OK $13B Zimmer-Biomet deal
ZMH set to acquire EU approval for $13B Biomet deal | The week in medtech M&A
Report: EU to clear Zimmer’s $13B Biomet deal
Medtronic clears all anti-trust hurdles for Covidien acquisition
ZMH proposes to mollify EU anti-trust regulators on pending, $13B acquisition Biomet | The week in medtech M&A
Zimmer proposes divestitures for EU regulators in Biomet deal
EU, Zimmer agree to extend review of Biomet merger
Medtronic offers EU concessions in $43 billion Covidien deal
Medtronic reveals leadership team after mega-merger with Covidien | The week in medtech M&A
EuroZone anti-trust regulators to rule next month on $43B Covidien buy
